Search Results - Alip, A.
- Showing 1 - 4 results of 4
-
1
-
2
Afatinib versus gefitinib or erlotinib in first-line setting for Malaysia patients with EGFR mutant advanced lung adenocarcinoma by Chai, Chee Shee, Liam, Chong Kin, Lin, O. Po, Pang, Yong Kek, Ho, G. F., Alip, A., Wong, C. K., Poh, M. E.
Published 2019Get full text
Get full text
Get full text
Article -
3
Comparison of pattern of disease progression and prevalence of acquired T790M mutation in Malaysia patients with EGFR mutant lung adenocarcinoma upon failure of first-line afatinib... by Chai, Chee Shee, Lin, O. Po, Liam, Chong Kin, Pang, Yong Kek, Ho, G. F., Alip, A., Wong, Chee Kuan, Poh, Mau Ern, Tan, Jiunn Liang
Published 2019Get full text
Get full text
Get full text
Article -
4
